Cough Frequency in Chronic Obstructive Pulmonary Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Acute exacerbations of COPD remain a common cause of morbidity and are associated with a sustained increase in the normal respiratory symptoms of dyspnoea, cough, and sputum volume and purulence. It has previously been shown that a change in cough symptoms occurs in 51.7% of exacerbations in COPD. We wish to record cough during a COPD exacerbation to determine whether this can be a objective marker of exacerbation duration and severity.
| Condition |
|---|
|
COPD Exacerbation |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Objective Measure of COPD Exacerbation Using the Hull Automated Cough Recorder. Verifying Use of Automated Recording Systems in Measuring Symptoms Associated With a COPD Exacerbation |
- Change in recorded cough counts/hr [ Time Frame: 5 days ] [ Designated as safety issue: No ]The primary objective is to evaluate the effectiveness of Hull Automated Cough Counter in recording transition of an acute COPD exacerbation. Change in no coughs/hr will be measured between start of exacerbation (day 0) to day 5 of exacerbation
- compare cough/hr measured via Hull automated cough counter with that of Phillips 45 day cough monitor [ Time Frame: 45 days ] [ Designated as safety issue: No ]The Key secondary endpoint will be to validate automated cough counts measured via the HACC with those measured via the Phillips 45CM at day 1, 5, 20 and 45. Cough monitor results will be compared using a bland altman plot, to determine if the systems are comparative with on another
| Estimated Enrollment: | 30 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Acute COPD exacerbation
Patients admitted in to hospital with an acute exacerbation of COPD
|
Detailed Description:
Acute exacerbations of COPD remain a common cause of morbidity and are associated with a sustained increase in the respiratory symptoms of dyspnoea, cough, sputum volume and sputum purulence. Cough is one of the most commonly reported and key symptoms in COPD patients. Cough can also be a useful factor in finding patients at risk of progressive airflow obstruction and cough along with the breathlessness is the major cause of distress in patients with chronic obstructive airways disease (COPD). There is limited literature looking into cough and COPD especially objective assessments.
in clinical practice and in most clinical trials scoring systems ie quality of life questionnaires or visual analogue scores, have been used to measure COPD exacerbation severity, although these may give an indication of the perceived severity of the symptom, they are inherently subjective and may be influenced by other factors. Shortfalls have prompted the development of cough recorders as an objective measure of this symptom. With this in mind we propose recruit 30 subjects with non-infective exacerbations of COPD and monitor their cough frequency as an inpatient in acute exacerbation and for 45 days post hospital discharge in order to elucidate the natural history of cough during and after an exacerbation.
Eligibility| Ages Eligible for Study: | 40 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Hospital admissions
Inclusion Criteria:
- Male/females aged between 40-80 years.
- Previous diagnosis of COPD.
- Acute exacerbation of COPD requiring treatment with antibiotics and/or corticosteroids.
- Symptoms of increased breathlessness, cough, sputum volume or sputum purulence.
- Acute exacerbation of COPD hospitalised within 48 hrs of study participation.
- On a stable therapeutic regimen for COPD for 8 weeks prior to inclusion.
- Known history of cigarette smoking at least 10 pack yrs.
- Willing and able to comply with study procedures.
- Able to provide written informed consent to participate.
Exclusion Criteria:
- Acute exacerbation of COPD within 8 weeks prior to inclusion.
- Clinically significant or unstable concurrent disease e.g. left ventricular failure, diabetes mellitus.
- On long-term oxygen therapy.
Contacts and Locations| Contact: Caroline e wright, Bsc | 01482 624067 | c.e.wright@hull.ac.uk |
| Contact: Jaymin morjaria, MD | 01482 624067 | jaymin.morjaria@hey.nhs.uk |
| United Kingdom | |
| Redspiratory medicine, Clinical trials Unit, Castle Hill hospital | Recruiting |
| Cottingham, East Yorkshire, United Kingdom, HU16 5JQ | |
| Contact: Karen Welburn 01482 624009 k.welburn@hull.ac.uk | |
| Contact: Caroline E Wright, Bsc 01482 624067 c.e.wright@hull.ac.uk | |
| Principal Investigator: Alyn H Morice, MD, MPHIL | |
| Principal Investigator: | Alyn H Morice, MD, MPhil | Hull and East Yorkshire Hospitals NHS Trust |
More Information
No publications provided
| Responsible Party: | Prof A H Morice, Professor of Respiratory Medicine, Hull and East Yorkshire Hospitals NHS Trust |
| ClinicalTrials.gov Identifier: | NCT01405222 History of Changes |
| Other Study ID Numbers: | 25042011 |
| Study First Received: | July 28, 2011 |
| Last Updated: | October 16, 2012 |
| Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Keywords provided by Hull and East Yorkshire Hospitals NHS Trust:
|
exacerbation COPD Cough |
Additional relevant MeSH terms:
|
Lung Diseases Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 19, 2013